Capitalizing on the Autophagic Response for Treatment of Liver Disease Caused by Alpha-1-Antitrypsin Deficiency and Other Genetic Diseases

BioMed Research International - United States
doi 10.1155/2014/459823
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Alpha 1-Antitrypsin Deficiency and Liver Disease.

BMJ
1981English

Liver Organoids Reproduce Alpha-1 Antitrypsin Deficiency-Related Liver Disease

Hepatology International
Hepatology
2019English

Gene Targeted Therapeutics for Liver Disease in Alpha-1 Antitrypsin Deficiency

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2009English

Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease

Annals of the American Thoracic Society
PulmonaryRespiratory Medicine
2016English

Alpha-1-Antitrypsin Deficiency

2020English

Alpha-1 Antitrypsin Deficiency

Journal of insurance medicine (New York, N.Y.)
Medicine
2015English

Alpha‐1‐Antitrypsin Deficiency

English

Safety and Efficacy of Alpha-1-Antitrypsin Augmentation Therapy in the Treatment of Patients With Alpha-1-Antitrypsin Deficiency

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2009English

Orphan Designation: Alpha-1 Antitrypsin (Inhalation Use), Treatment of Emphysema Secondary to Congenital Alpha-1-Antitrypsin Deficiency

Case Medical Research
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy